These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25591676)

  • 21. Dysferlin Gene Mutation Spectrum in a Large Cohort of Chinese Patients with Dysferlinopathy.
    Jin SQ; Yu M; Zhang W; Lyu H; Yuan Y; Wang ZX
    Chin Med J (Engl); 2016 Oct; 129(19):2287-93. PubMed ID: 27647186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Homozygous Variant in DYSF Gene Is Associated with Autosomal Recessive Limb Girdle Muscular Dystrophy R2/2B.
    Spadafora P; Qualtieri A; Cavalcanti F; Di Palma G; Gallo O; De Benedittis S; Cerantonio A; Citrigno L
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late onset in dysferlinopathy widens the clinical spectrum.
    Klinge L; Dean AF; Kress W; Dixon P; Charlton R; Müller JS; Anderson LV; Straub V; Barresi R; Lochmüller H; Bushby K
    Neuromuscul Disord; 2008 Apr; 18(4):288-90. PubMed ID: 18396043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic features and genetic findings in 2 chinese families with Miyoshi distal myopathy.
    Ro LS; Lee-Chen GJ; Lin TC; Wu YR; Chen CM; Lin CY; Chen ST
    Arch Neurol; 2004 Oct; 61(10):1594-9. PubMed ID: 15477515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reverse engineering gene network identifies new dysferlin-interacting proteins.
    Cacciottolo M; Belcastro V; Laval S; Bushby K; di Bernardo D; Nigro V
    J Biol Chem; 2011 Feb; 286(7):5404-13. PubMed ID: 21119217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation.
    Dominov JA; Uyan Ö; McKenna-Yasek D; Nallamilli BRR; Kergourlay V; Bartoli M; Levy N; Hudson J; Evangelista T; Lochmuller H; Krahn M; Rufibach L; Hegde M; Brown RH
    Ann Clin Transl Neurol; 2019 Apr; 6(4):642-654. PubMed ID: 31019989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.
    Szymanska S; Rokicki D; Karkucinska-Wieckowska A; Szymanska-Debinska T; Ciara E; Ploski R; Grajkowska W; Pronicki M
    Folia Neuropathol; 2014; 52(4):452-6. PubMed ID: 25574751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymyositis without Beneficial Response to Steroid Therapy: Should Miyoshi Myopathy be a Differential Diagnosis?
    Scalco RS; Lorenzoni PJ; Lynch DS; Martins WA; Jungbluth H; Quinlivan R; Becker J; Houlden H
    Am J Case Rep; 2017 Jan; 18():17-21. PubMed ID: 28053302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translational research and therapeutic perspectives in dysferlinopathies.
    Barthélémy F; Wein N; Krahn M; Lévy N; Bartoli M
    Mol Med; 2011; 17(9-10):875-82. PubMed ID: 21556485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysferlinopathy: a clinical and histopathological study of 28 patients from India.
    Nalini A; Gayathri N
    Neurol India; 2008; 56(3):379-85; discussion 386-7. PubMed ID: 18974568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected].
    Nilsson MI; Laureano ML; Saeed M; Tarnopolsky MA
    Muscle Nerve; 2013 May; 47(5):740-7. PubMed ID: 23519732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
    Ten Dam L; van der Kooi AJ; Rövekamp F; Linssen WH; de Visser M
    Neuromuscul Disord; 2014 Dec; 24(12):1097-102. PubMed ID: 25176504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morpholino-Mediated Exons 28-29 Skipping of Dysferlin and Characterization of Multiexon-skipped Dysferlin using RT-PCR, Immunoblotting, and Membrane Wounding Assay.
    Anwar S; Yokota T
    Methods Mol Biol; 2023; 2587():183-196. PubMed ID: 36401031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel DYSF mutations in Thai patients with distal myopathy.
    Liewluck T; Pongpakdee S; Witoonpanich R; Sangruchi T; Pho-Iam T; Limwongse C; Thongnoppakhun W; Boonyapisit K; Sopassathit V; Phudhichareonrat S; Suthiponpaisan U; Raksadawan N; Goto K; Hayashi YK; Nishino I
    Clin Neurol Neurosurg; 2009 Sep; 111(7):613-8. PubMed ID: 19493611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
    Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
    FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the DYSF mutational spectrum in a large cohort of patients.
    Krahn M; Béroud C; Labelle V; Nguyen K; Bernard R; Bassez G; Figarella-Branger D; Fernandez C; Bouvenot J; Richard I; Ollagnon-Roman E; Bevilacqua JA; Salvo E; Attarian S; Chapon F; Pellissier JF; Pouget J; Hammouda el H; Laforêt P; Urtizberea JA; Eymard B; Leturcq F; Lévy N
    Hum Mutat; 2009 Feb; 30(2):E345-75. PubMed ID: 18853459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments.
    Anwar S; Yokota T
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dysferlin expression in limb-girdle muscular dystrophy and Miyoshi myopathy: analysis of 45 cases].
    Ren SC; Yan CZ; Li MX; Liu SP; Wu JL; Zhao YY; Li W; Li DN
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1486-90. PubMed ID: 17785089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Miyoshi myopathy associated with spine rigidity and multiple contractures: a case report.
    Bardakov SN; Titova AA; Nikitin SS; Nikitins V; Sokolova MO; Tsargush VA; Yuhno EA; Vetrovoj OV; Carlier PG; Sofronova YV; Isaev АА; Deev RV
    BMC Musculoskelet Disord; 2024 Feb; 25(1):146. PubMed ID: 38365661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.
    Petersen JA; Kuntzer T; Fischer D; von der Hagen M; Huebner A; Kana V; Lobrinus JA; Kress W; Rushing EJ; Sinnreich M; Jung HH
    BMC Neurol; 2015 Oct; 15():182. PubMed ID: 26444858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.